MINISTERS should review the use of a widely used anti-flu medication, scientists have said after new research has questioned the efficacy of the drug.
The study suggested that Tamiflu, which is used to prevent and treat influenza, shortens flu symptoms by between a day and half a day. But the authors said there is "no good evidence" to support claims that it reduces flu-related hospital admissions or the complications of influenza.
The researchers, from The Cochrane Collaboration and the British Medical Journal (BMJ), also claimed that taking the drug could increase a person's risk of nausea and vomiting. And when used as a preventative treatment it can stop people developing flu symptoms but may not prevent them from spreading flu to others, the authors said.
The findings of the review may cause further questions to be raised about the Government's stockpile of the drug. During the swine flu pandemic in 2009, the Scottish Government spent millions of pounds accumulating supplies of Tamiflu. A total of 3.5 million doses of the drug, and another anti-viral Relenza, were made available. In the event, less than 100,000 doses were handed out.
"The BMJ and Cochrane issue a joint call to government and health policy decision makers the world over, asking in light of the latest findings from the Cochrane Review, would you make the same recommendations today, choosing to stockpile Tamiflu?" a BMJ spokeswoman said.
Pharmaceutical company Roche said it "fundamentally disagrees" with the latest review, which was based on data from 20 clinical study reports.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article